XML 62 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Collaborative Arrangement - Additional Information (Detail) - USD ($)
12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Total revenue $ 99,951,000 $ 105,136,000 $ 94,864,000    
Abbott Agreement [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement payment received 60,800,000 60,800,000      
Total revenue 5,700,000 16,000,000.0 12,000,000.0    
Upfront and milestone fee payment included in deferred revenue 9,200,000 14,900,000      
Collaboration revenue recognized included in balance at beginning of period 5,700,000 4,700,000 5,000,000.0    
Abbott Agreement [Member] | Contract Life to Date [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Total revenue 51,600,000        
Abbott Agreement [Member] | Upfront Payment [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement payment received         $ 25,000,000
Abbott Agreement [Member] | Milestone Payment [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement payment received   $ 15,000,000 $ 10,800,000 $ 10,000,000  
Abbott Agreement [Member] | PMA Received After December 31, 2022, but Before June 30, 2023 [Member] | TRANSCEND Clinical Trial [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement additional potential milestone payments receivable 27,000,000        
Abbott Agreement [Member] | PMA Received On or After June 30, 2023 [Member] | TRANSCEND Clinical Trial [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement additional potential milestone payments receivable 24,000,000        
Abbott Agreement [Member] | Maximum [Member] | PMA Milestone [Member] | TRANSCEND Clinical Trial [Member]          
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]          
Collaborative arrangement additional potential milestone payments receivable $ 30,000,000